New Products In Brief
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific’s next-generation Promus Element Plus drug-eluting stent; Biotronik’s first-of-its-kind MRI-safe ICD; BSD Medical’s BSD-2000 cervical cancer treatment. More new products.
You may also be interested in...
Blood-Collection Groups Must Test Blood For Chagas Disease Parasite, US FDA Says
Donated blood must be tested by blood-collection groups for evidence of infection with Trypanosoma cruzi, a parasite that causes Chagas disease – either for donation purposes or for use in manufacturing a medical device – FDA says in final guidance released Dec. 5.
New Products In Brief
Recent launches and approvals include overseas debuts of Abbott’s Absorb bioabsorbable vascular scaffold and Medtronic’s next-generation CoreValve Evolut transcatheter aortic heart valve.
New Competition, Procedure Declines Challenge Abbott Vascular In Second Quarter
Abbott’s stent business was up against an approximately 5% decline in U.S. percutaneous coronary intervention procedures in the past quarter, on top of persistent pricing pressures and the U.S. launch earlier this year of Medtronic’s Resolute Integrity.